We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Oncology Information System to Interface with Proton Radiotherapy System

By HospiMedica staff writers
Posted on 19 Jun 2008
Varian Medical Systems, Inc. More...
(Palo Alto, CA, USA) and Still River Systems, Inc. announced an agreement to develop an interface between Varian's Aria oncology information system and Still River Systems' (Littleton, MA, USA) Monarch250 proton beam radiotherapy (PBRT) system.

"Aria is a powerful oncology information system that manages the clinical processes unique to radiotherapy treatments for cancer,” said Corey Zankowski, Varian's senior director for product management. "In addition to providing a complete electronic medical record for oncology, Aria is exceptional at recording and verifying the numerous treatment parameters and instruction sets required for complex radiotherapy treatments. Varian is committed to creating a completely open environment and ensuring connectivity between Aria and most commonly used radiation delivery devices, including proton treatment systems. As such, Varian is pleased to be developing, with the support of Still River, an interface with the Monarch250 proton therapy system.”

"It is Varian's aim to bring the familiar workflow, look and feel of Aria into the proton environment, to ease the transition of staff from conventional radiotherapy to proton therapy,” added James DeFilippi, Varian's business manager for integrated proton solutions.

Still River Systems will provide technical assistance to Varian engineers, who will develop the interface to allow important "record and verify” functionality across the two systems. "We are developing the Monarch250 proton therapy system to support existing clinical processes. The Monarch250 Aria interface will allow cancer centers to integrate proton therapy within their existing radiation therapy practices,” remarked Skip Rosenthal, Ph.D., Still River Systems vice president, clinical systems.

Any new ARIA interface that facilitates record and verify functions with new radiotherapy delivery technologies are subject to 510(k) clearance by the U.S. Food and Drug Administration (FDA), and would need such clearance prior to any clinical deployment.

Varian Medical Systems is a world-leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies software for managing comprehensive cancer clinics, radiotherapy centers, and medical oncology practices. Varian is a supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.


Related Links:
Varian Medical Systems
Still River Systems

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.